Compare Compendia Bioscience vs Ingenuity Systems
Customers evaluate the quality of Compendia Bioscience's products using the following success metrics.
Overview
Compendia Bioscience is 18 yrs old and is based in United States.
Compendia Bioscience is dedicated to curing cancers through the application of genomic data by providing researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes. In October 2012, Compendia Bioscience was acquired by Life Technologies. The valuation of Compendia Bioscience was undisclosed. Other terms of the deal were not released.
Ingenuity Systems is 26 yrs old and is based in United States.
Ingenuity Systems is a provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. The company's solutions are used by researchers and clinicians at hundreds of pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.
Demo Video
Leadership
Arul Chinnaiyan (Founder)
Mark Hung (Founder)
Investors
Life Technologies Corporation, National Institutes of Health
QIAGEN, Accel
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Compendia Bioscience has not claimed their profile.
Work for Compendia Bioscience? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Compendia Bioscience?
Claim your profile now.
Information not available because Ingenuity Systems has not claimed their profile.
Work for Ingenuity Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Ingenuity Systems?
Claim your profile now.